Crossmark Global Holdings’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$484K Buy
6,270
+244
+4% +$17.8K 0.01% 875
2026
Q1
$393K Sell
6,026
-69
-1% -$5.13K 0.01% 919
2025
Q4
$483K Buy
6,095
+500
+9% +$38.3K 0.01% 847
2025
Q3
$408K Buy
5,595
+3
+0.1% +$220 0.01% 970
2025
Q2
$424K Sell
5,592
-2,296
-29% -$163K 0.01% 951
2025
Q1
$600K Buy
7,888
+702
+10% +$52.3K 0.01% 806
2024
Q4
$475K Sell
7,186
-84
-1% -$5.88K 0.01% 855
2024
Q3
$507K Buy
7,270
+118
+2% +$7.1K 0.01% 860
2024
Q2
$379K Buy
+7,152
New +$434K 0.01% 946

Other funds holding SOLV

Crossmark Global Holdings's SOLV Position: Q2 2026 in Review

Crossmark Global Holdings increased its Solventum (SOLV) stake by 4% in Q2 2026, buying an estimated $17.8K and bringing the position to 6,270 shares worth $484K. The position accounts for 0.01% of the portfolio, ranked #875.

Crossmark Global Holdings first reported a position in SOLV in Q2 2024 and has held it in 9 quarters since. The position peaked at $600K in Q1 2025. 875 funds tracked by Wall St. Rank hold SOLV as of Q2 2026.

  • Crossmark Global Holdings held 6,270 shares of Solventum worth $484K as of Q2 2026.
  • Crossmark Global Holdings bought 244 Solventum shares in Q2 2026, an estimated $17.8K.
  • Solventum made up 0.01% of Crossmark Global Holdings's portfolio in Q2 2026, its #875 holding.
  • Crossmark Global Holdings first reported a position in Solventum in Q2 2024 and has held it in 9 quarters since.
  • Crossmark Global Holdings's Solventum position peaked at $600K in Q1 2025.
  • 875 funds tracked by Wall St. Rank held Solventum as of Q2 2026.

Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.